Y Mine
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 6
- Musculoskeletal pain and rehabilitation 3
- Surgery 5
- Hip and Femur Fractures 3
- Co-authors
- Takuya Kamimura (4 shared papers)Yoshimi Matsumoto (3 shared papers)S Kuwahara (7 shared papers)Shinichi Goto (6 shared papers)Yoshihiro Yokota (5 shared papers)Fumiaki Ikeda (4 shared papers)Motohiro Nishida (6 shared papers)Yoshihisa Fujino (8 shared papers)
In The Last Decade
Y Mine
27 papers receiving 466 citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 230
- Endocrinology 62
- Pharmacology 202
- Applied Microbiology and Biotechnology 20
- Infectious Diseases 76
Countries citing papers authored by Y Mine
This map shows the geographic impact of Y Mine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Mine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Mine more than expected).
Fields of papers citing papers by Y Mine
This network shows the impact of papers produced by Y Mine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Mine. The network helps show where Y Mine may publish in the future.
Co-authors
The 25 scholars most cited alongside Y Mine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 111 | |
| 2 | 1979 | 84 | |
| 3 | 1984 | 77 | |
| 4 | In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. | 1969 | 65 |
| 5 | 1996 | 37 | |
| 6 | 2020 | 36 | |
| 7 | 1979 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 1990 | 16 | |
| 10 | Immunogenicity of cefazolin. | 1970 | 11 |
| 11 | 1979 | 10 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 1980 | 4 | |
| 20 | 2020 | 3 |
About Y Mine
Y Mine is a scholar working on Pharmacology, Surgery, Molecular Medicine, General Health Professions and Molecular Biology, having authored 27 papers that have together received 546 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (5 papers), Workplace Health and Well-being (4 papers), Hip and Femur Fractures (3 papers), Musculoskeletal pain and rehabilitation (3 papers), Infection Control and Ventilation (2 papers), Emergency and Acute Care Studies (2 papers) and Building Energy and Comfort Optimization (2 papers). The work is most often cited by research in Molecular Medicine (230 citations), Endocrinology (62 citations), Pharmacology (202 citations), Applied Microbiology and Biotechnology (20 citations) and Infectious Diseases (76 citations). Y Mine has collaborated with scholars based in Japan and Thailand. Frequent co-authors include Takuya Kamimura, Yoshimi Matsumoto, S Kuwahara, Shinichi Goto, Yoshihiro Yokota, Fumiaki Ikeda, Motohiro Nishida, Yoshihisa Fujino, Hitoshi Kojo and Tomohiro Ishimaru. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity, Disability and Rehabilitation, Occupational Medicine and Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.